NFE2L2 and chronic obstructive pulmonary disease: Recently it has been demonstrated that pharmacological activation of Nrf2 by sulforaphane, a potent activator of Nrf2, leads to restoration of corticosteroid responsiveness in alveolar macrophages from COPD patients [56].